#USA #New York #Class Action #Gross Law #Altimmune

Gross Law Firm Encourages Shareholders of Altimmune to Take Action

In recent developments, The Gross Law Firm has issued a critical notice to shareholders of Altimmune, Inc. (NASDAQ: ALT), urging them to consider joining a class action lawsuit before the deadline of October 6, 2025. This initiative targets investors who purchased shares during a specific class period, from August 10, 2023, to June 25, 2025.

Overview of the Allegations

The impetus for this class action stems from allegations pertaining to misleading statements made by Altimmune executives, particularly around the results of their IMPACT Phase 2b MASH trial involving Pemvidutide. On June 26, 2025, Altimmune released topline results from the trial, revealing a disheartening lack of statistical significance in key endpoints concerning fibrosis reduction. Analysts noted that while there was an observable positive trend in fibrosis improvement, the trial's placebo response was higher than anticipated, raising red flags about the reliability of the outcomes presented.

In the wake of this announcement, significant volatility ensued in the company's stock price. Closing at $7.71 on June 25, it plummeted to $3.61 the following day, representing a staggering 53.2% drop in value. Such a dramatic shift reflects the serious implications of the alleged inaccuracies that shareholders faced, prompting the necessity for a class action.

Next Steps for Shareholders

Shareholders who believe they are eligible are strongly encouraged to connect with The Gross Law Firm to discuss potential lead plaintiff appointments. However, it’s important to note that being appointed as a lead plaintiff is not a prerequisite for participating in any potential financial recovery from the case. Interested parties can register their details through the firm’s submission portal.

Once registered, shareholders will be enrolled in a portfolio monitoring software that provides real-time updates throughout the legal proceedings. This proactive approach ensures investors remain informed about the status of the class action as it unfolds.

Why Choose The Gross Law Firm?

The Gross Law Firm is a nationally recognized entity specializing in class actions and investor rights. The firm’s mission is to safeguard the interests of those adversely affected by deceptive business practices. With a commitment to corporate accountability, they strive to recuperate losses incurred by investors due to misleading information or omissions that artificially inflated stock prices.

As the deadline approaches, it is imperative for eligible shareholders to act swiftly to secure their participation in this case. Engaging with The Gross Law Firm could be a vital step toward seeking justice and potential recovery of losses stemming from the low stock performance.

For further inquiries or to begin the registration process, interested parties can reach the firm directly:

• - Email: [email protected]
• - Phone: (646) 453-8903

This alert serves as both a call to action and a reminder of the crucial role that due diligence plays in protecting investment rights. The Gross Law Firm is dedicated to ensuring that corporate actions align with legal standards and investor expectations in this evolving landscape.